Precigen (PGEN) Tax Provisions (2014 - 2025)
Precigen (PGEN) posted quarterly Tax Provisions of $3000.0 for Q2 2025, up 100.18% year-over-year from $1498.7 in Q2 2024, and up 103.45% quarter-over-quarter from -$87000.0 in Q4 2024.
Powered by 
Analysis
Precigen (PGEN) Tax Provisions (2014 - 2025) Analysis & Trends
Precigen (PGEN) has reported Tax Provisions for 12 consecutive years, with $3000.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Tax Provisions rose 100.18% year-over-year to $3000.0; the TTM figure through Mar 2026 stood at $3000.0 (up 100.17% YoY), while the FY2025 annual figure was $3000.0, up 100.17% from the prior year.
- Tax Provisions grew to $3000.0 in Q2 2025 per PGEN's latest filing, from -$87000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $13000.0 in Q4 2021 and bottomed at -$1.7 million in Q2 2024.
- Historically, Tax Provisions has averaged -$152764.7 across 5 years, with a median of -$55000.0 in 2023.
- Annual changes were most pronounced in 2023 — Tax Provisions slumped 4250.0% — and 2024, when it soared 300.0%.
- Precigen's Tax Provisions stood at $13000.0 in 2021, then slumped by 38.46% to $8000.0 in 2022, then plunged by 4250.0% to -$332000.0 in 2023, then jumped by 73.8% to -$87000.0 in 2024, then jumped by 103.45% to $3000.0 in 2025.
- Business Quant data shows PGEN's Tax Provisions at $3000.0 in Q2 2025, -$87000.0 in Q4 2024, and $12000.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Precigen | 2.56 Bn | 2.56 Bn | 52.17 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 3,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | -1.69 Mn |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | -332,000.00 |
| Sep 30, 2023 | -6,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Mar 31, 2023 | -55,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | -50,000.00 |
| Jun 30, 2022 | -89,000.00 |
| Mar 31, 2022 | -58,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | -61,000.00 |
| Jun 30, 2021 | -60,000.00 |
| Mar 31, 2021 | -52,000.00 |
| Dec 31, 2020 | 48,000.00 |
| Sep 30, 2020 | -50,000.00 |
| Jun 30, 2020 | -120,000.00 |